Steven M. Fruchtman - 13 Mar 2024 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: PRESIDENT, CHIEF EXECUTIVE OFF, Director
Signature: /s/ Mark Guerin, Attorney-in-Fact
Issuer symbol: TRAW
Transactions as of: 13 Mar 2024
Net transactions value: -$7,854
Form type: 4
Filing time: 15 Mar 2024, 17:36:28 UTC
Previous filing: 09 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+23,111	+38%		83,519	13 Mar 2024	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$7,854	-8,727	-10%	$0.9000	74,792	14 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-23,111	-33%	$0.000000	46,222	13 Mar 2024	Common Stock	23,111		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.